Energy » Fossil Fuels | Changsheng Biotechnology Co. Ltd.

Changsheng Biotechnology Co. Ltd. A | Ownership

Companies that own Changsheng Biotechnology Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Caitong Fund Management Co., Ltd.
27,964,230
6.93%
27,964,230
0.19%
01/26/2017
SWS MU Fund Management Co., Ltd.
11,589,732
2.87%
11,589,732
0.17%
01/26/2017
Huatai-PineBridge Fund Management Co., Ltd.
11,283,498
2.8%
11,283,498
0.11%
01/26/2017
Truvalue Asset Management Co. Ltd.
9,477,686
2.35%
9,477,686
0.32%
01/26/2017
China Merchants Wealth Asset Management Co. Ltd.
9,365,304
2.31%
0
0.19%
09/30/2017
China Merchants Fund Management Co., Ltd.
414,600
0.1%
-367,441
0.01%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
361,800
0.09%
361,800
0.01%
12/31/2017
E Fund Management Co., Ltd.
236,038
0.06%
-56,600
0%
12/31/2017
GF Fund Management Co., Ltd.
236,000
0.06%
-14,962,566
0%
12/31/2017
Chang Xin Asset Management Co., Ltd.
233,600
0.06%
-1,771,945
0%
12/31/2017

About Changsheng Biotechnology Co.

View Profile
Address
No. 1615 Yueda Road
Changchun Jilin 130103
China
Employees -
Website -
Updated 07/08/2019
Changsheng Bio-technology Co., Ltd. engages in the manufacture, research and development, and sale of human vaccines. Its products include vaccine for DTC combines, rabies F and V, varicella, influenza, and hepatitis A. The company was founded on August 18, 1992 and is headquartered in Changchun, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.